BMO Capital initiates coverage on Gilead Sciences (NASDAQ: GILD) with a Market Perform rating and a price target of $102.00.Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE